Fisetin overcomes non-targetability of mutated KRAS induced YB-1 signaling in colorectal cancer cells and improves radiosensitivity by blocking repair of radiation-induced DNA double-strand breaks-Reference-Cited by-同舟云学术

Fisetin overcomes non-targetability of mutated KRAS induced YB-1 signaling in colorectal cancer cells and improves radiosensitivity by blocking repair of radiation-induced DNA double-strand breaks

Published:2023-11 Issue: Volume:188 Page:109867
ISSN:0167-8140
Container-title:Radiotherapy and Oncology
language:en
Short-container-title:Radiotherapy and Oncology

Author:

Khozooei Shayan,Veerappan Soundaram,Bonzheim Irina,Singer Stephan,Gani Cihan,Toulany Mahmoud

Funder

Deutsche Forschungsgemeinschaft

Eberhard Karls University Tübingen

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology,Hematology

Reference46 articles.

1. Metastatic colorectal cancer. First line therapy for unresectable disease;Aparicio;J Clin Med,2020

2. Surgical management of colorectal cancer;Rodriguez-Bigas,2003

3. Radiotherapy for colorectal cancer: Current standards and future perspectives;Häfner;Visc Med,2016

4. Efficacy and safety of bevacizumab plus chemotherapy compared to chemotherapy alone in previously untreated advanced or metastatic colorectal cancer: a systematic review and meta-analysis;Botrel;BMC Cancer,2016

5. Pathological complete response following different neoadjuvant treatment strategies for locally advanced rectal cancer: A systematic review and meta-analysis;Hoendervangers;Ann Surg Oncol,2020

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Polyphenols in the Prevention and Treatment of Colorectal Cancer: A Systematic Review of Clinical Evidence;Nutrients;2024-08-16

2. A comprehensive view on the fisetin impact on colorectal cancer in animal models: Focusing on cellular and molecular mechanisms;Animal Models and Experimental Medicine;2024-08-13